Conformal Medical, Inc., will be acquired by W. L. Gore & Associates this year, bringing along several cardiovascular devices, including left atrial appendage occlusion (LAAO) systems and endovascular technologies. "We are pleased to join forces with a partner that reflects our belief that the investigational CLAAS AcuFORM Device can prove to be a transformative solution for stroke prevention. Our stakeholders will realize the value of this partnership as we bring this therapy through the clinical and regulatory process and eventually make it available to patients worldwide," said James Reinstein, President and CEO of Conformal Medical, in a PR Newswire press release. "This partnership combines Conformal's deep expertise in LAAO with Gore's world-class capabilities in technology development, distribution and operations. It will enable us to leverage Gore's global presence, accelerating our mission of shaping the future of stroke prevention." Image Credit: Piai – stock.adobe.com